Company / Capital Expenditures
Glucotrack, Inc. Capital Expenditures History
FY2014-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$23.0K
FY2020
5-year range
$5.4K / $143.7K
FY2016-FY2020
Trend
+328.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +328% YoY in FY2020, a notable deviation from the 6-year average annual change of +127%.
Based on SEC 10-K filings.
$23,000 in FY2020 with a 5-year CAGR of -18.6%.
Improved from $19,467 to $23,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -45.7%
- 5-Year CAGR
- -18.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.6%, indicating a declining trend.
- In FY2020, capital expenditures increased 328.2% year-over-year.
- Peak capital expenditures was recorded in FY2017.
- Lowest capital expenditures in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $23.0K | +328.2% |
| FY2019 | $5.4K | -72.4% |
| FY2018 | $19.5K | -86.5% |
| FY2017 | $143.7K | +126.5% |
| FY2016 | $63.5K | -1.2% |
| FY2015 | $64.3K | +466.2% |
| FY2014 | $11.3K | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026